Life Long Learning Prep Course WEBCAST ONLY (2019): Module 1: Oncology, Urinary Diversion and Adrenal + Core

Specifically designed for anyone unable to get away from the office to attend the Live Course, the Webcast option delivers the same great content. Purchase of the Webcast features simultaneous presentation slides and audio recorded from the Live Course and includes access to online course materials.

The purpose of the Life Long Learning Prep Course: A Focused Review is to prepare attendees for the ABU knowledge assessment. This course will be practice-focused and will offer practical and clinically-specific updates. It will highlight the AUA guidelines and address general urology practice issues that can be expected on the knowledge assessment. The course will model the changes to the ABU exam by covering Core/General Urology on the first day followed by Module 1: Oncology, Urinary Diversion and Adrenal on the second day.

Sample multiple choice practice questions as well as case-based discussions and debates will be utilized to prepare attendees for the upcoming knowledge assessment. For more information on the changes to the exam, please visit www.abu.org/recertification.

The Webcast Only purchase includes access to the webcast of the course (Core Urology and Module 1: Oncology, Urinary Diversion and Adrenal content) and electronic handouts. Webcasts will be available to view on Wednesday,  September 11, 2019.

 

Registration Fees
 

Membership Category

 

AUA Member$845.00
AUA Non-Member$1045.00

Target Audience

  • Urologists

Learning Objectives

Core Urology

At the conclusion of this activity, participants will be able to:

  1. Review generally accepted urological practices for superior patient care.
  2. Discuss a core knowledge of urology necessary for taking the Knowledge Assessment.
  3. Examine the most recent changes and additions to the AUA guidelines.

Module 1: Oncology & Urinary Diversion

At the conclusion of this activity, participants will be able to:

  1. Discuss the appropriate indications for and use diagnostic tests in the management of urologic cancers.
  2. Enhance ability to make guideline-based decisions regarding management of common urologic cancers.
  3. Recognize and execute appropriate measures to prevent and manage complications resulting for management intervention for urologic cancers.
  4. Develop and employ a disease stage appropriate surveillance schedule during post management follow-up of urologic cancers.
Course summary
Course opens: 
03/12/2019
Course expires: 
09/11/2022
Price:
$1,045.00
Rating: 
0
Scientific Program
Core Urology
Friday, September 6, 2019
7:00 – 8:00 amRegistration & Breakfast
8:00 – 8:15 amIntroduction & ARS
Mark L. gonzalgo, MD, PhD & Daniel H. Williams, IV, MD
8:15 – 9:30 amGeneral Cancer 1 (Localized/Advanced Prostate, Localized Kidney)
Mark L. Gonzalgo, MD, PhD
9:30 – 9:45 amBreak
9:45 – 10:45 amGeneral Cancer 2 (Bladder, Upper Tract TCC, Advanced Kidney)
Siamak Daneshmand, MD
10:45 – 11:30 amMedical Urology: Hypertension, Fluids and Electrolytes, Nephrology
Sarah Elfering, MD
11:30 am – 12:15 pmTrauma
Caleb Kovell, MD
12:15 – 1:15 pmLunch
1:15 – 2:00 pmGeriatric Urology
Tomas L. Griebling, MD, MPH
2:00 – 2:45 pmComplications of Urologic Surgery
Jay D. Raman, MD
2:45 – 3:00 pmBreak
3:00 – 3:45 pmEndocrine
Daniel H. Williams, IV, MD & Sarah Elfering
3:45 – 4:30 pmStones (not metabolic stones)
Kevan A. Sternberg, MD
4:30 – 5:00 pmProstate Evaluation/Biopsy
Jay D. Raman, MD
5:00 – 5:30 pmInfection
Robert J. Evans, MD, FACS
5:30 – 6:15 pmNetworking Reception

Saturday, September 7, 2019
7:00 – 7:30 amRegistration & Breakfast
7:30 – 8:00 amRadiology/Radiation Safety
Robert Marcovich, MD
8:00 – 9:30 amOffice Based Practice and Guidelines (UTI's hematuria, genital pain, etc.)
Tomas L. Griebling, MD, MPH
9:30 – 9:45 amBreak

Module 1: Oncology, Urinary Diversion and Adrenal
Moderator: Mark L. Gonzalgo, MD, PhD
September 7, 2019
9:45 – 10:15 amUpper Tract Tumors/Urinary Diversion
Siamak Daneshmand, MD
10:15 – 11:00 amProstate Cancer – Localized
Mark L. Gonzalgo, MD, PhD
11:00 – 11:45 amTesticular Cancer
Badrinath R. Konety, MD, MBA
11:45 am – 12:45 pmLunch
12:45 – 1:30 pmPenile/Urethral Cancer
Badrinath R. Konety, MD, MBA
1:30 – 2:15 pmUrothelial Bladder Cancer
Siamak Daneshmand, MD
2:15 – 3:00 pmAdrenal
Viraj A. Master, MD, PhD
3:00 – 3:15 pmBreak
3:15 – 4:00 pmKidney Cancer
Viraj A. Master, MD, PhD
4:00 – 4:45 pmProstate Cancer – Advanced
Mark L. Gonzalgo, MD, PhD
4:45 – 5:30 pmMock Multiple Choice Exam and Review
All Faculty
5:30 pmAdjourn

METHOD OF PARTICIPATION: 

Learners will participate in this online educational activity by taking the pretest, viewing the webcast and completing the posttest and evaluation. To claim CME credit for this enduring material, learners must complete the posttest, passing with 80% accuracy and submit the program evaluation.

Estimated time to complete this activity:16.50 hours

Release Date: September, 2019
Expiration Date: September, 2022

ACCREDITATION: 

The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: 

The American Urological Association designates this enduring activity for a maximum of 16.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER LEARNERS: 

The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

EVIDENCE BASED CONTENT: 

It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA DISCLOSURE POLICY: 

All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

RESOLUTION OF IDENTIFIED CONFLICT OF INTEREST: 

All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES: 

The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Available Credit

Accreditation Period

Course opens: 
03/12/2019
Course expires: 
09/11/2022

Price

Price:
$1,045.00
Please login or register to take this course.

Must choose 1 of the 4 content specific modules. Registration includes the Core/General Urology (Day 1) as well as 1 of the 4 specified modules (Day 2). 

The Webcast Only purchase includes access to the webcast of the course (Core Urology and Module 1: Oncology, Urinary Diversion and Adrenal content) and electronic handouts. Webcasts will be available to view on Wednesday,  September 11, 2019.


REGISTRATION FEES
 

 Webcast Only
AUA Member$845.00
AUA Non-Member$1045.00

CANCELLATION POLICY


Live Course

An administrative fee of 15% is assessed if registration is cancelled up to six weeks prior to the course. If registration is cancelled four to six weeks from the course, the cancellation fee is 50% of the registration fee paid. No registration fees will be refunded less than four weeks prior to the course.

Webcast

Cancellations must be made no later than one week prior to the live course. Subscription fees will not be refunded after the cancellation period. Purchases after the live course date are not eligible for a refund.

Registration Transfer

Customers switching from an option of lesser value to a higher value will be required to pay the difference in cost between the two options. Switching to an option of lesser value from a higher value must be made no later than to six weeks prior to the course and will be subject to an administrative fee of 15% of the cost of the course from which they are transferring. Transfer of registration from a higher value option to an option of lesser value past six weeks prior to the course will not receive a refund.

Cancellations must be made in writing. Requests may be made via mail or fax to 410-689-3912.  Questions? Call 1-800-908-9414 or email registration@AUAnet.org.

AUA Education & Research reserves the right to cancel this course if a minimum enrollment is not reached before August 2, 2019. If AUA Education & Research cancels this course, notification will be sent by August 9, 2019.